当前位置:主页 > 科技论文 > 基因论文 >

达巴万星前体A40926 B生产菌种的基因工程改造

发布时间:2018-10-11 11:06
【摘要】:Nonomuraea sp.ATCC 39727可以通过次级代谢生产A40926 B组分,该物质可以作为生产新型糖肽类抗生素达巴万星的前体,这种抗生素与替考拉宁结构类似,在临床试验中,其活性更强,半衰期更长。本研究在实验室前期经过诱变改造、原生质体诱变得到的突变菌株A416-B4的基础上,对其进行基因工程改造,以期简化生产工艺并提高A40926 B产量,为工业化生产奠定基础。首先,本研究针对突变株A416-B4进行了接合转移(基因敲除)遗传操作系统的优化。在优化后遗传操作系统的基础上,构建敲除乙酰转移酶基因dbv23敲除质粒pKdbv23,利用同源重组双交换敲除dbv23基因,得到工程菌A416-△dbv23。对该工程菌进行发酵验证,发现其发酵主产物为A40926 B组分,而不再产生A40926 PB组分,且A40926 B组分摇瓶发酵单位达到1577 mg/L,较出发菌株A416-B4提高了94%。构建含两个调节基因dbv3、dbv4的整合型表达质粒,将两个质粒整合到A416-△dbv23中,得到二株工程菌株:A416-△dbv23-dbv3、A416-△dbv23-dbv4。对工程菌的发酵情况进行考察,确定导入dbv4基因效果略优于dbv3,A416-△dbv23-dbv4的发酵单位最高,摇瓶单位达到1707 mg/L,较A416-△dbv23提高了8.2%,较出发菌株A416-B4提高了110%。
[Abstract]:Nonomuraea sp.ATCC 39727 can produce component A40926B by secondary metabolism, which can be used as precursor of dabavanxin, a new glycopeptide antibiotic, which is similar to teicoplanin in structure and has stronger activity and longer half-life in clinical trials. On the basis of mutagenesis and protoplast mutagenesis of mutant strain A416-B4 in the early stage of laboratory, genetic engineering was carried out to simplify the production process and increase the yield of A40926B, thus laying a foundation for industrial production. First of all, the genetic operating system of A416-B4 was optimized for conjugation transfer (knockout). On the basis of the optimized genetic operating system, the dbv23 knockout plasmid pKdbv23, of knockout acetyltransferase gene was constructed, and the engineering strain A416- dbv23. was obtained by using homologous recombination double exchange knockout dbv23 gene. The main product of the fermentation was A40926B, but no A40926 PB was produced, and the fermentation unit of A40926B in shaking flask reached 1577 mg/L, which was 94 494% higher than that of the original strain A416-B4. An integrated expression plasmid containing two regulatory genes, dbv3,dbv4, was constructed, two plasmids were integrated into A416- dbv23, and two engineering strains, A416- dbv23-dbv3,A416- dbv23-dbv4., were obtained. The fermentation of engineering bacteria was investigated. The results showed that the effect of introducing dbv4 gene was slightly better than that of dbv3,A416- dbv23-dbv4. The shaking flask unit reached 1707 mg/L, and increased 8.2% compared with A416- dbv23, and 110% higher than the original strain A416-B4.
【学位授予单位】:上海医药工业研究院
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:Q78;TQ927

【参考文献】

相关期刊论文 前8条

1 李煜;张菁;;FDA批准Dalvance(达巴万星)用于治疗皮肤感染[J];中国感染与化疗杂志;2015年04期

2 PAN WenQin;KANG QianJin;WANG Lei;BAI LinQuan;DENG ZiXin;;Asm8, a specific LAL-type activator of 3-amino-5-hydroxy-benzoate biosynthesis in ansamitocin production[J];Science China(Life Sciences);2013年07期

3 龙燕;黄运昌;朱春燕;莫洪;朱辉;;糖肽类抗生素A40926高产菌株的选育[J];中国医药工业杂志;2013年02期

4 黄灵丽;沈晓放;陈少欣;;糖肽类抗生素A40926B产生菌的培养基优化及菌种选育[J];中国医药工业杂志;2012年04期

5 沈晓放;陈少欣;;半合成糖肽类抗生素达巴万星前体A40926的生物合成[J];中国医药工业杂志;2010年02期

6 李航;阮林高;魏维;朱丽;陈代杰;戈梅;;东方拟无枝酸菌HCCB10007中vcm8基因的敲除及无氯万古霉素产生菌的构建[J];中国新药杂志;2010年01期

7 周雨朦;洪文荣;阮林高;陈代杰;戈梅;;氯离子对东方拟无枝酸菌发酵产物的影响[J];中国抗生素杂志;2008年05期

8 尚新艳;阮丽军;许激扬;陈代杰;;第二代糖肽类抗生素的研究进展[J];中国抗生素杂志;2007年05期



本文编号:2263964

资料下载
论文发表

本文链接:https://www.wllwen.com/kejilunwen/jiyingongcheng/2263964.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户daa4f***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com